查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984881

全球微藻生物技术市场：依应用、产品类型、终端用户和技术划分－全球产业分析、市场规模、趋势、主要参与者、区域展望及预测（2025-2035）

Global Microalgae Biotechnology Market: By Application, Product Type, End User, Technology, - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
出版日期: | 出版商: Astute Analytica | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

全球微藻生物技术市场正经历重大变革，反映出其在众多产业中日益增长的重要性。 2025年，该市场规模约为39亿美元，预计将快速成长，到2035年将超过102.1亿美元。在2026-2035年的预测期内，该市场将以约10.1%的复合年增长率成长。如此强劲的成长是由几个关键因素驱动的，这些因素正在改变微藻应用和生产技术的模式。

其中一个关键的成长驱动因素是对高价值藻类衍生成分日益增长的需求。 这包括一些特殊化合物，例如ω-3脂肪酸、色素、抗氧化剂和生物活性分子，它们在医药、营养保健品、化妆品和功能性食品等广泛领域都有应用。高昂的价格以及消费者对天然和永续成分日益增长的偏好正在推动该领域的投资和创新。

主要市场趋势

微藻生物技术市场呈现出独特的结构，主要参与者之间存在适度的整合，而基层企业则高度分散。这种双重性既反映了成熟产业巨头的存在，也反映了由中小企业、新创公司和利基创新者组成的多元化市场环境。 在旨在整合能力、拓展产品组合和加速技术进步的併购和策略联盟浪潮的推动下，市场正经历着快速转型。

在主要参与者中，DIC 公司凭藉其 "Earthrise Nutritionals" 品牌，已确立了其在螺旋藻生产领域不可撼动的领导地位。 DIC 总部位于日本，利用其位于加利福尼亚州和中国的战略性大型养殖设施，高效地供应全球市场。其竞争优势源自于数十年来在大规模微藻养殖、品质控制和供应链管理方面的经验和专业知识。 Earthrise Nutritionals 以其一致的高品质螺旋藻产品而闻名，这些产品广泛应用于膳食补充剂和功能性食品等领域。 市场上另一家重要的参与者是帝斯曼-菲美意公司，该公司是 omega-3 脂肪酸领域的领导者。该公司专注于利用裂殖壶菌微藻透过吞噬发酵生产EPA和DHA这两种关键的ω-3脂肪酸成分。这种创新方法绕过了传统的海洋来源，例如鱼油，而鱼油正面临着来自永续性和供应限制方面的日益严格的审查。透过利用发酵技术，帝斯曼-菲美尼希正在革新传统的鱼油市场，提供一种可扩展、可持续且高纯度的替代方案，以满足食品、药品和膳食补充剂领域对植物性ω-3脂肪酸日益增长的需求。

主要成长驱动因素

全球 "蛋白质转化" 正成为微藻生物技术市场成长的关键驱动因素。预计到2050年，世界人口将达到约97亿，传统农业系统正面临满足日益增长的蛋白质需求的巨大压力。传统的蛋白质生产方式，特别是畜牧业，不仅消耗大量资源，还会带来严重的生态风险，包括森林砍伐、温室气体排放和淡水过度消耗。这些环境挑战凸显了迫切需要可持续的替代方案，以便在不进一步破坏地球生态系统的前提下，提供充足且营养丰富的蛋白质。

新兴机会

微藻生物技术的一个新前沿领域是 "客製化藻类" ​​的开发，这些藻类是透过基因工程改造的，旨在增强特定特性并提高生产效率。与传统藻类不同，这些客製化藻类经过改造，可以显着提高产量或直接生产有用的化合物，具有革新该行业的潜力。虽然欧盟等地区对基因改造生物（GMO）的监管架构仍然严格，但基因改造微藻正在美国和亚洲部分地区的生物技术领域逐渐被接受。

优化障碍

虽然微藻可以利用阳光和简单的营养物质生长，使其培养成本相对较低，但下游製程有许多挑战，可能会阻碍整体市场成长。微藻的收穫、脱水和干燥都是能源密集且成本高昂的工艺，通常占总生产成本的30%之多。高成本源自于微藻细胞漂浮在大量水中，使得分离和浓缩过程复杂且资源消耗庞大。

目录

第一章 摘要整理：全球微藻生物技术市场

第二章 研究方法与架构

  • 研究目标
  • 产品概述
  • 市场区隔
  • 质性研究
    • 一手和二手资料来源
  • 量化研究
    • 一手与二手资讯
  • 主要调查受访者分布：依地区划分
  • 本研究的假设
  • 市场规模估算
  • 资料三角验证

第三章 全球微藻生物技术市场概述

  • 产业价值链分析
    • 原料及零件供应商
    • 製造商
    • 经销商
    • 终端用户
  • 行业展望
    • 全球饲料统计数据
  • PESTLE 分析
  • 波特五力分析
    • 供应商议价能力
    • 买方议价能力
    • 替代品威胁
    • 新进入者威胁
    • 竞争强度
  • 市场成长与展望
    • 市场收入估计与预测（2020-2035）
    • 价格趋势分析

第四章 全球微藻生物技术市场分析

  • 竞争格局概览
    • 市场集中度比
    • 公司占有率分析（价值，%），2025 年
    • 竞争对手分析与基准分析

第五章 全球微藻生物技术市场分析

  • 市场动态与趋势
    • 成长驱动因素
    • 限制因素
    • 机遇
    • 主要趋势
  • 市场规模及预测（2020-2035 年）
    • 依产品类型划分
    • 依应用程式划分
    • 依技术划分
    • 依最终用户划分
    • 依地区划分

第六章 北美微藻生物技术市场分析

第七章 欧洲微藻生物技术市场

分析

第八章：亚太地区微藻生物技术市场分析

第九章：中东与非洲微藻生物技术市场分析

第十章：南美洲微藻生物技术市场分析

第十一章：公司简介

  • AlgaEnergy S.A.
  • Algatech Ltd.
  • Algenol Biofuels Inc.
  • Allmicroalgae-Natural Products S.A.
  • AstaReal AB
  • BlueBioTech Int. GmbH
  • Cellana Inc.
  • Corbion N.V.
  • Cyanotech Corporation
  • DIC Corporation
  • E.I.D. Parry (India) Limited
  • 富士化学工业株式会社
  • Heliae Development, LLC
  • MicroBio Engineering, Inc.
  • Necton S.A.
  • Parry Nutraceuticals
  • Phycom Microalgae
  • Roquette KlA¶tze GmbH &Co. KG
  • Seambiotic Ltd.
  • Solazyme (TerraVia Holdings, Inc.)
  • 其他主要参与者

第十二章附录

简介目录
Product Code: AA01261680

The global microalgae biotechnology market is undergoing a significant transformation, reflecting its growing importance across multiple industries. Valued at approximately USD 3.9 billion in 2025, the market is projected to expand rapidly, surpassing USD 10.21 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of around 10.1% during the forecast period from 2026 to 2035. Such robust expansion is driven by several key factors that are reshaping the landscape of microalgae applications and production technologies.

One of the primary growth drivers is the increasing demand for high-value algal derivatives. These include specialized compounds such as omega-3 fatty acids, pigments, antioxidants, and bioactive molecules that have wide-ranging applications in pharmaceuticals, nutraceuticals, cosmetics, and functional foods. The premium pricing and growing consumer preference for natural, sustainable ingredients are fueling investments and innovation in this sector.

Noteworthy Market Developments

The microalgae biotechnology market exhibits a unique structure characterized by moderate consolidation among leading companies, while remaining highly fragmented at the lower tiers. This dual nature reflects both the presence of established industry giants and a diverse landscape of smaller players, startups, and niche innovators. The market is undergoing rapid transformation, driven by a wave of mergers, acquisitions, and strategic partnerships that aim to consolidate capabilities, expand product portfolios, and accelerate technological advancement.

Among the top players, DIC Corporation, operating under the brand Earthrise Nutritionals, stands as the undisputed leader in Spirulina production. Headquartered in Japan, DIC leverages massive cultivation facilities strategically located in California and China, enabling them to serve global markets efficiently. Their dominance is rooted in decades of experience and expertise in large-scale microalgae cultivation, quality control, and supply chain management. Earthrise Nutritionals has built a reputation for consistent, high-quality Spirulina products that cater to diverse applications ranging from dietary supplements to functional foods.

Another major force in the market is DSM-Firmenich, a powerhouse in the Omega-3 fatty acids sector. They specialize in producing EPA and DHA-two critical Omega-3 compounds-using Schizochytrium microalgae through heterotrophic fermentation. This innovative approach bypasses traditional marine sources such as fish oil, which are increasingly scrutinized for sustainability and supply constraints. By harnessing fermentation technology, DSM-Firmenich is disrupting the conventional fish oil market, offering a scalable, sustainable, and high-purity alternative that meets the growing demand for plant-based Omega-3 ingredients in food, pharmaceuticals, and nutraceuticals.

Core Growth Drivers

The global protein transition is emerging as a critical driver of growth in the microalgae biotechnology market. With the world's population projected to reach approximately 9.7 billion by 2050, traditional agricultural systems face immense pressure to meet escalating protein demands. Conventional protein production methods, particularly livestock farming, are not only resource-intensive but also pose severe ecological risks, including deforestation, greenhouse gas emissions, and excessive freshwater use. These environmental challenges highlight the urgent need for sustainable alternatives that can provide sufficient, nutritious protein without further degrading the planet's ecosystems.

Emerging Opportunity Trends

The emerging frontier in microalgae biotechnology is the development of "designer algae," genetically engineered strains tailored to enhance specific traits and improve production efficiency. Unlike traditional strains, these designer algae are modified to deliver significantly higher yields or produce valuable compounds directly, offering transformative potential for the industry. While regulatory frameworks surrounding genetically modified organisms (GMOs) remain stringent in regions like the European Union, the markets in the United States and parts of Asia are progressively embracing genetically modified microalgae within their biotechnology sectors.

Barriers to Optimization

While cultivating microalgae is relatively inexpensive due to their ability to grow using sunlight and simple nutrients, the downstream processing stages present significant challenges that could hamper overall market growth. Harvesting, dewatering, and drying microalgae are particularly energy-intensive and costly steps, often accounting for up to 30% of the total production costs. This high expenditure arises because microalgae cells are suspended in large volumes of water, making their separation and concentration a complex and resource-demanding process.

Detailed Market Segmentation

By Product Type, in 2025, the Microalgae Biomass segment held the largest share of the microalgae biotechnology market, accounting for 38.95% of the total. This prominence is largely due to the economic advantages of selling whole-cell biomass compared to the costly downstream extraction processes required to isolate specific compounds. Techniques such as supercritical CO2 extraction, while effective for obtaining oils and other high-value components, involve complex, multi-step procedures that significantly increase production costs. By marketing whole microalgae biomass directly, producers can bypass these expensive extraction steps, reducing both capital and operational expenditures.

By Technology Type, in 2025, the Cultivation Open Pond Systems segment dominated the microalgae biotechnology market by securing the largest share, accounting for 48.52% of the total market. This leadership position highlights the continued preference for open pond systems as a cost-effective and efficient technology for cultivating microalgae. One of the primary reasons for their widespread use is the significantly lower capital and operational costs compared to alternative technologies such as Closed Photobioreactors (PBRs).

By End-User, the Pharmaceutical and Biotechnology Companies segment represents the largest end-user group, holding a commanding 42% share of the market. This significant market presence reflects a broader shift in how microalgae are perceived and utilized, marking a transition from being viewed merely as traditional agricultural commodities to becoming advanced, high-value biotech ingredients. The evolution of microalgae applications into sophisticated therapeutic and biotechnological tools highlights the growing recognition of their potential within cutting-edge scientific fields.

By application, the pharmaceuticals and nutraceuticals segment commands the largest share, accounting for 37.23% of the market. This dominance is closely tied to the nature of modern biotechnology, which requires substantial capital expenditures (CAPEX) for development, production, and regulatory compliance. The high costs associated with these advanced technologies necessitate significant profit margins to justify investment and sustain innovation. As a result, sectors that offer the highest return on investment naturally rise to prominence.

Segment Breakdown

By Product Type

  • Microalgae Biomass
  • Pigments & Colorants
  • Astaxanthin
  • Beta-Carotene
  • Phycocyanin
  • Others
  • Omega-3 Fatty Acids
  • Proteins & Peptides
  • Bioactive Compounds & Antioxidants
  • Biofuels
  • Biodiesel
  • Bioethanol
  • Biogas
  • Others

By Application

  • Pharmaceuticals & Nutraceuticals
  • Cosmetics & Personal Care
  • Biofuels & Renewable Energy
  • Agriculture & Animal Feed
  • Wastewater Treatment & Environmental Management
  • Food & Beverages
  • Others

By Technology

  • Cultivation & Growth Technologies
  • Open Pond Systems
  • Photobioreactors (PBRs)
  • Hybrid Systems
  • Downstream Processing
  • Harvesting & Dewatering
  • Extraction & Purification
  • Formulation

By End User

  • Pharmaceutical & Biotechnology Companies
  • Food & Nutraceutical Manufacturers
  • Cosmetic & Personal Care Companies
  • Biofuel Producers
  • Agriculture & Animal Feed Companies
  • Environmental Services & Wastewater Treatment
  • Research & Academic Institutes

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America

Geography Breakdown

  • North America stands out as the primary innovation engine and a high-value consumer hub within the global microalgae biotechnology market, commanding control over more than 43% of the market share. This leadership is especially pronounced in the United States, where the industry has undergone a remarkable transformation. After experiencing the setback of the "algae-for-fuel" failure in the 2010s, the region successfully shifted its focus toward a more refined and sophisticated "precision biology" approach. This new model emphasizes the development and commercialization of specialized, high-value derivatives extracted from microalgae, rather than relying on the sheer volume of raw biomass.

By 2024, North America's microalgae biotechnology market will contribute approximately $1.12 billion to the global revenue, underscoring the region's dominance. This substantial figure is driven primarily by the premium pricing associated with pharmaceutical-grade algae products, which command significantly higher values compared to bulk biomass sales. The emphasis on quality, targeted applications, and advanced biotechnological processes has allowed North America to position itself as a leader in producing highly specialized algae-based products.

Leading Market Participants

  • AlgaEnergy S.A.
  • Algatech Ltd.
  • Algenol Biofuels Inc.
  • Allmicroalgae - Natural Products S.A.
  • AstaReal AB
  • BlueBioTech Int. GmbH
  • Cellana Inc.
  • Corbion N.V.
  • Cyanotech Corporation
  • DIC Corporation
  • E.I.D. Parry (India) Limited
  • Fuji Chemical Industries Co., Ltd.
  • Heliae Development, LLC
  • MicroBio Engineering, Inc.
  • Necton S.A.
  • Parry Nutraceuticals
  • Phycom Microalgae
  • Roquette KlA¶tze GmbH & Co. KG
  • Seambiotic Ltd.
  • Solazyme (TerraVia Holdings, Inc.)
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Microalgae Biotechnology Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Source
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Source
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Microalgae Biotechnology Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material/Component Provider
    • 3.1.2. Manufacturer
    • 3.1.3. Distributor
    • 3.1.4. End User
  • 3.2. Industry Outlook
    • 3.2.1. Global Feed Statistics
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis

Chapter 4. Global Microalgae Biotechnology Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Microalgae Biotechnology Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Microalgae Biomass
        • 5.2.1.1.2. Pigments & Colorants
          • 5.2.1.1.2.1. Astaxanthin
          • 5.2.1.1.2.2. Beta-Carotene
          • 5.2.1.1.2.3. Phycocyanin
          • 5.2.1.1.2.4. Others
        • 5.2.1.1.3. Omega-3 Fatty Acids
        • 5.2.1.1.4. Proteins & Peptides
        • 5.2.1.1.5. Bioactive Compounds & Antioxidants
          • 5.2.1.1.5.1. Biofuels
          • 5.2.1.1.5.2. Biodiesel
          • 5.2.1.1.5.3. Bioethanol
          • 5.2.1.1.5.4. Biogas
          • 5.2.1.1.5.5. Others
    • 5.2.2. By Application
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Pharmaceuticals & Nutraceuticals
        • 5.2.2.1.2. Cosmetics & Personal Care
        • 5.2.2.1.3. Biofuels & Renewable Energy
        • 5.2.2.1.4. Agriculture & Animal Feed
        • 5.2.2.1.5. Wastewater Treatment & Environmental Management
        • 5.2.2.1.6. Food & Beverages
        • 5.2.2.1.7. Others
    • 5.2.3. By Technology
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Cultivation & Growth Technologies
        • 5.2.3.1.2. Open Pond Systems
        • 5.2.3.1.3. Photobioreactors (PBRs)
        • 5.2.3.1.4. Hybrid Systems
        • 5.2.3.1.5. Downstream Processing
        • 5.2.3.1.6. Harvesting & Dewatering
        • 5.2.3.1.7. Extraction & Purification
        • 5.2.3.1.8. Formulation
    • 5.2.4. By End User
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Pharmaceutical & Biotechnology Companies
        • 5.2.4.1.2. Food & Nutraceutical Manufacturers
        • 5.2.4.1.3. Cosmetic & Personal Care Companies
        • 5.2.4.1.4. Biofuel Producers
        • 5.2.4.1.5. Agriculture & Animal Feed Companies
        • 5.2.4.1.6. Environmental Services & Wastewater Treatment
        • 5.2.4.1.7. Research & Academic Institutes
    • 5.2.5. By Region
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. North America
          • 5.2.5.1.1.1. The U.S.
          • 5.2.5.1.1.2. Canada
          • 5.2.5.1.1.3. Mexico
        • 5.2.5.1.2. Europe
          • 5.2.5.1.2.1. Western Europe
            • 5.2.5.1.2.1.1. The UK
            • 5.2.5.1.2.1.2. Germany
            • 5.2.5.1.2.1.3. France
            • 5.2.5.1.2.1.4. Italy
            • 5.2.5.1.2.1.5. Spain
            • 5.2.5.1.2.1.6. Rest of Western Europe
          • 5.2.5.1.2.2. Eastern Europe
            • 5.2.5.1.2.2.1. Poland
            • 5.2.5.1.2.2.2. Russia
            • 5.2.5.1.2.2.3. Rest of Eastern Europe
        • 5.2.5.1.3. Asia Pacific
          • 5.2.5.1.3.1. China
          • 5.2.5.1.3.2. India
          • 5.2.5.1.3.3. Japan
          • 5.2.5.1.3.4. South Korea
          • 5.2.5.1.3.5. Australia & New Zealand
          • 5.2.5.1.3.6. ASEAN
          • 5.2.5.1.3.7. Rest of Asia Pacific
        • 5.2.5.1.4. Middle East & Africa
          • 5.2.5.1.4.1. UAE
          • 5.2.5.1.4.2. Saudi Arabia
          • 5.2.5.1.4.3. South Africa
          • 5.2.5.1.4.4. Rest of MEA
        • 5.2.5.1.5. South America
          • 5.2.5.1.5.1. Argentina
          • 5.2.5.1.5.2. Brazil
          • 5.2.5.1.5.3. Rest of South America

Chapter 6. North America Microalgae Biotechnology Market Analysis

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Technology
    • 6.2.4. By End User
    • 6.2.5. By Country

Chapter 7. Europe Microalgae Biotechnology Market Analysis

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Technology
    • 7.2.4. By End User
    • 7.2.5. By Country

Chapter 8. Asia Pacific Microalgae Biotechnology Market Analysis

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Technology
    • 8.2.4. By End User
    • 8.2.5. By Country

Chapter 9. Middle East & Africa Microalgae Biotechnology Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Technology
    • 9.2.4. By End User
    • 9.2.5. By Country

Chapter 10. South America Microalgae Biotechnology Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Technology
    • 10.2.4. By End User
    • 10.2.5. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product Type landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. AlgaEnergy S.A.
  • 11.2. Algatech Ltd.
  • 11.3. Algenol Biofuels Inc.
  • 11.4. Allmicroalgae - Natural Products S.A.
  • 11.5. AstaReal AB
  • 11.6. BlueBioTech Int. GmbH
  • 11.7. Cellana Inc.
  • 11.8. Corbion N.V.
  • 11.9. Cyanotech Corporation
  • 11.10. DIC Corporation
  • 11.11. E.I.D. Parry (India) Limited
  • 11.12. Fuji Chemical Industries Co., Ltd.
  • 11.13. Heliae Development, LLC
  • 11.14. MicroBio Engineering, Inc.
  • 11.15. Necton S.A.
  • 11.16. Parry Nutraceuticals
  • 11.17. Phycom Microalgae
  • 11.18. Roquette KlA¶tze GmbH & Co. KG
  • 11.19. Seambiotic Ltd.
  • 11.20. Solazyme (TerraVia Holdings, Inc.)
  • 11.21. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets - Macro Economic Outlook/Indicators